296 related articles for article (PubMed ID: 1551416)
1. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.
Goretzki L; Schmitt M; Mann K; Calvete J; Chucholowski N; Kramer M; Günzler WA; Jänicke F; Graeff H
FEBS Lett; 1992 Feb; 297(1-2):112-8. PubMed ID: 1551416
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).
Kobayashi H; Schmitt M; Goretzki L; Chucholowski N; Calvete J; Kramer M; Günzler WA; Jänicke F; Graeff H
J Biol Chem; 1991 Mar; 266(8):5147-52. PubMed ID: 1900515
[TBL] [Abstract][Full Text] [Related]
3. Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer.
Schmitt M; Goretzki L; Jänicke F; Calvete J; Eulitz M; Kobayashi H; Chucholowski N; Graeff H
Biomed Biochim Acta; 1991; 50(4-6):731-41. PubMed ID: 1801751
[TBL] [Abstract][Full Text] [Related]
4. Human tumor cell urokinase-type plasminogen activator (uPA): degradation of the proenzyme form (pro-uPA) by granulocyte elastase prevents subsequent activation by plasmin.
Schmitt M; Kanayama N; Jänicke F; Hafter R; Graeff H
Adv Exp Med Biol; 1991; 297():111-28. PubMed ID: 1837419
[TBL] [Abstract][Full Text] [Related]
5. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing.
Dahl SW; Halkier T; Lauritzen C; Dolenc I; Pedersen J; Turk V; Turk B
Biochemistry; 2001 Feb; 40(6):1671-8. PubMed ID: 11327826
[TBL] [Abstract][Full Text] [Related]
6. Cathepsins B and L in synovial fluids from patients with rheumatoid arthritis and the effect of cathepsin B on the activation of pro-urokinase.
Ikeda Y; Ikata T; Mishiro T; Nakano S; Ikebe M; Yasuoka S
J Med Invest; 2000 Feb; 47(1-2):61-75. PubMed ID: 10740981
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
[TBL] [Abstract][Full Text] [Related]
8. In vitro activation of pro-cathepsin B by three serine proteinases: leucocyte elastase, cathepsin G, and the urokinase-type plasminogen activator.
Dalet-Fumeron V; Guinec N; Pagano M
FEBS Lett; 1993 Oct; 332(3):251-4. PubMed ID: 8405467
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
[TBL] [Abstract][Full Text] [Related]
10. Pro-urokinase-type plasminogen activator is a substrate for hepsin.
Moran P; Li W; Fan B; Vij R; Eigenbrot C; Kirchhofer D
J Biol Chem; 2006 Oct; 281(41):30439-46. PubMed ID: 16908524
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
Petersen LC
Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
[TBL] [Abstract][Full Text] [Related]
12. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
Behrendt N; List K; Andreasen PA; Danø K
Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
[TBL] [Abstract][Full Text] [Related]
13. The role of cysteine and serine proteases in colorectal carcinoma.
Herszènyi L; Plebani M; Carraro P; De Paoli M; Roveroni G; Cardin R; Tulassay Z; Naccarato R; Farinati F
Cancer; 1999 Oct; 86(7):1135-42. PubMed ID: 10506696
[TBL] [Abstract][Full Text] [Related]
14. Regulation of plasminogen activation by human U937 promonocytic cells.
Duval-Jobe C; Parmely MJ
J Biol Chem; 1994 Aug; 269(33):21353-7. PubMed ID: 8063761
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated urokinase-type plasminogen activator: biological and clinical significance.
Schmitt M; Jänicke F; Moniwa N; Chucholowski N; Pache L; Graeff H
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):611-22. PubMed ID: 1515091
[TBL] [Abstract][Full Text] [Related]
16. Elastase released from human granulocytes stimulated with N-formyl-chemotactic peptide prevents activation of tumor cell prourokinase (pro-uPA).
Schmitt M; Kanayama N; Henschen A; Hollrieder A; Hafter R; Gulba D; Jänicke F; Graeff H
FEBS Lett; 1989 Sep; 255(1):83-8. PubMed ID: 2529137
[TBL] [Abstract][Full Text] [Related]
17. Cysteine and serine proteases in gastric cancer.
Plebani M; Herszènyi L; Cardin R; Roveroni G; Carraro P; Paoli MD; Rugge M; Grigioni WF; Nitti D; Naccarato R
Cancer; 1995 Aug; 76(3):367-75. PubMed ID: 8625115
[TBL] [Abstract][Full Text] [Related]
18. Increased cell-surface urokinase in advanced ovarian cancer.
Kobayashi H; Moniwa N; Sugimura M; Shinohara H; Ohi H; Terao T
Jpn J Cancer Res; 1993 Jun; 84(6):633-40. PubMed ID: 8340251
[TBL] [Abstract][Full Text] [Related]
19. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.
Orgel D; Schröder W; Hecker-Kia A; Weithmann KU; Kolkenbrock H; Ulbrich N
Clin Chem Lab Med; 1998 Sep; 36(9):697-702. PubMed ID: 9804393
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis.
Farinati F; Herszényi L; Plebani M; Carraro P; De Paoli M; Cardin R; Roveroni G; Rugge M; Nitti D; Grigioni WF; D'Errico A; Naccarato R
Carcinogenesis; 1996 Dec; 17(12):2581-7. PubMed ID: 9006092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]